Market Closed -
Japan Exchange
07:00:00 05/07/2024 BST
|
5-day change
|
1st Jan Change
|
375
JPY
|
-0.53%
|
|
+0.27%
|
0.00%
|
03-19 |
Medical Net, Inc. and NU-DENT Co., Ltd. completed the acquisition of Avision Co., Ltd from Achievable Co., Ltd., AMBS Co., Ltd., Siriporn Phipatpongpan, Suchai Yenruedee, Kanokporn Pattanichanon, Thitiphat Chunkampanart, Khanchai Phatanaphanchai and others.
|
CI
| 03-14 |
Medical Net, Inc. and NU-DENT Co., Ltd. agreed to acquire Avision Co., Ltd from Achievable Co., Ltd., AMBS Co., Ltd., Siriporn Phipatpongpan, Suchai Yenruedee, Kanokporn Pattanichanon, Thitiphat Chunkampanart, Khanchai Phatanaphanchai and others for TBH80 million.
|
CI
|
Fiscal Period: May |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
4,374
|
3,097
|
1,980
|
5,558
|
4,108
|
3,555
|
Enterprise Value (EV)
1 |
3,101
|
2,146
|
1,785
|
5,072
|
3,748
|
2,826
|
P/E ratio
|
49.7
x
|
30.4
x
|
26.6
x
|
42.2
x
|
10.6
x
|
30.4
x
|
Yield
|
0.25%
|
0.35%
|
0.31%
|
0.39%
|
0.54%
|
0.64%
|
Capitalization / Revenue
|
2.51
x
|
1.39
x
|
0.68
x
|
1.67
x
|
1.1
x
|
0.79
x
|
EV / Revenue
|
1.78
x
|
0.96
x
|
0.61
x
|
1.52
x
|
1
x
|
0.63
x
|
EV / EBITDA
|
18.6
x
|
11.1
x
|
14.3
x
|
14.3
x
|
7.83
x
|
6.42
x
|
EV / FCF
|
24.3
x
|
-24.7
x
|
63.7
x
|
15.4
x
|
21.5
x
|
7.6
x
|
FCF Yield
|
4.12%
|
-4.05%
|
1.57%
|
6.49%
|
4.66%
|
13.2%
|
Price to Book
|
2.83
x
|
1.9
x
|
1.99
x
|
4.48
x
|
2.41
x
|
1.86
x
|
Nbr of stocks (in thousands)
|
10,773
|
10,773
|
8,081
|
8,618
|
8,816
|
9,045
|
Reference price
2 |
406.0
|
287.5
|
245.0
|
645.0
|
466.0
|
393.0
|
Announcement Date
|
31/08/18
|
30/08/19
|
31/08/20
|
31/08/21
|
31/08/22
|
31/08/23
|
Fiscal Period: May |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,740
|
2,236
|
2,917
|
3,330
|
3,745
|
4,500
|
EBITDA
1 |
167
|
194
|
125
|
355
|
479
|
440
|
EBIT
1 |
153
|
176
|
106
|
331
|
450
|
379
|
Operating Margin
|
8.79%
|
7.87%
|
3.63%
|
9.94%
|
12.02%
|
8.42%
|
Earnings before Tax (EBT)
1 |
125
|
151
|
103
|
253
|
536
|
250
|
Net income
1 |
88
|
102
|
79
|
129
|
384
|
116
|
Net margin
|
5.06%
|
4.56%
|
2.71%
|
3.87%
|
10.25%
|
2.58%
|
EPS
2 |
8.169
|
9.468
|
9.214
|
15.28
|
43.88
|
12.95
|
Free Cash Flow
1 |
127.6
|
-87
|
28
|
329.2
|
174.6
|
372
|
FCF margin
|
7.33%
|
-3.89%
|
0.96%
|
9.89%
|
4.66%
|
8.27%
|
FCF Conversion (EBITDA)
|
76.42%
|
-
|
22.4%
|
92.75%
|
36.46%
|
84.55%
|
FCF Conversion (Net income)
|
145.03%
|
-
|
35.44%
|
255.23%
|
45.48%
|
320.69%
|
Dividend per Share
2 |
1.000
|
1.000
|
0.7500
|
2.500
|
2.500
|
2.500
|
Announcement Date
|
31/08/18
|
30/08/19
|
31/08/20
|
31/08/21
|
31/08/22
|
31/08/23
|
Fiscal Period: May |
2020 S1
|
2021 S1
|
2022 S1
|
2022 Q3
|
2023 Q1
|
2023 S1
|
2023 Q3
|
2024 Q1
|
2024 S1
|
2024 Q3
|
---|
Net sales
1 |
-
|
1,592
|
1,702
|
889
|
971
|
1,997
|
1,128
|
1,099
|
2,342
|
1,313
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
180
|
249
|
126
|
92
|
192
|
68
|
22
|
169
|
62
|
Operating Margin
|
-
|
11.31%
|
14.63%
|
14.17%
|
9.47%
|
9.61%
|
6.03%
|
2%
|
7.22%
|
4.72%
|
Earnings before Tax (EBT)
1 |
-
|
127
|
328
|
129
|
103
|
221
|
26
|
44
|
192
|
-34
|
Net income
1 |
-
|
65
|
246
|
86
|
57
|
130
|
9
|
21
|
115
|
-69
|
Net margin
|
-
|
4.08%
|
14.45%
|
9.67%
|
5.87%
|
6.51%
|
0.8%
|
1.91%
|
4.91%
|
-5.26%
|
EPS
2 |
-
|
7.865
|
28.42
|
9.640
|
6.520
|
14.74
|
0.8700
|
2.410
|
12.80
|
-7.670
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
-
|
12/01/21
|
12/01/22
|
14/04/22
|
14/10/22
|
13/01/23
|
14/04/23
|
13/10/23
|
12/01/24
|
12/04/24
|
Fiscal Period: May |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
1,273
|
951
|
195
|
486
|
360
|
729
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
128
|
-87
|
28
|
329
|
175
|
372
|
ROE (net income / shareholders' equity)
|
4.89%
|
6.39%
|
6.28%
|
12.1%
|
26.6%
|
5.95%
|
ROA (Net income/ Total Assets)
|
5.23%
|
5.59%
|
3.5%
|
10.8%
|
10.7%
|
7.16%
|
Assets
1 |
1,682
|
1,824
|
2,258
|
1,198
|
3,592
|
1,621
|
Book Value Per Share
2 |
143.0
|
152.0
|
123.0
|
144.0
|
194.0
|
212.0
|
Cash Flow per Share
2 |
118.0
|
96.70
|
74.90
|
101.0
|
129.0
|
168.0
|
Capex
1 |
5
|
19
|
8
|
13
|
2
|
19
|
Capex / Sales
|
0.29%
|
0.85%
|
0.27%
|
0.39%
|
0.05%
|
0.42%
|
Announcement Date
|
31/08/18
|
30/08/19
|
31/08/20
|
31/08/21
|
31/08/22
|
31/08/23
|
|
1st Jan change
|
Capi.
|
---|
| 0.00% | 21.11M | | +18.33% | 83.89B | | -28.29% | 71.08B | | +0.99% | 26.77B | | +3.67% | 17.74B | | -9.99% | 17.24B | | +1.86% | 15.6B | | +79.98% | 13.84B | | -25.09% | 12.92B | | +74.41% | 12.87B |
Other Healthcare Facilities & Services
|